Skip to content

09969.HK

InnoCare Pharma Ltd.

HKSE · Healthcare · Biotechnology · CN

HKD 11.25
−3.60%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue3.3B2.3B1.0B738.5M625.4M
Cost of Revenue297.0M285.2M138.4M128.4M143.4M
Gross Profit3.0B2.0B871.0M610.1M482.0M
Operating Expenses
R&D Expense1.0B849.2M814.0M751.2M639.1M
SG&A Expense824.4M759.5M310.6M252.1M489.6M
General & Admin Expense92.8M179.2M47.9M48.6M51.0M
Selling & Marketing Expense313.2M580.0M262.8M203.6M438.6M
Other Expenses17.3M(37.0M)272.1M258.0M123.7M
Total Operating Expenses1.9B1.6B1.4B1.3B1.3B
Cost and Expenses2.2B1.9B1.5B1.4B1.4B
Operating Income (EBIT)1.2B440.6M(525.8M)(651.2M)(770.4M)
Non-Operating
Interest Income152.4M152.0M171.6M192.3M136.9M
Interest Expense55.9M53.6M33.8M35.0M17.0M
Net Interest Income96.5M98.3M137.8M157.3M119.9M
Other Non-Op Income/Expense136.1M198.2M73.2M6.9M(123.3M)
Non-Operating Income (excl Interest)———(42.0M)—
EBT (Pre-Tax Income)1.4B638.8M(452.6M)(644.2M)(893.7M)
Income Tax Expense15.2M11.3M263.0K1.4M—
Bottom Line
Net Income1.4B625.8M(440.6M)(631.3M)(886.6M)
Earnings from Cont. Ops1.4B627.5M(452.9M)(645.6M)(893.7M)
Earnings from Discont. Ops—————
Bottom Line Net Income1.4B625.8M(440.6M)(631.3M)(886.6M)
Per Share
Basic EPSHK$0.77HK$0.36(HK$0.26)(HK$0.37)(HK$0.60)
Diluted EPSHK$0.77HK$0.36(HK$0.26)(HK$0.37)(HK$0.60)
Revenue Per ShareHK$1.89HK$1.30HK$0.60HK$0.43HK$0.42
Shares
Basic Shares Outstanding1.8B1.8B1.7B1.7B1.5B
Diluted Shares Outstanding1.8B1.8B1.7B1.7B1.5B
Profitability Metrics
EBITDA1.3B555.9M(442.9M)(516.6M)(808.3M)
D&A87.2M115.3M106.3M92.6M68.4M
EBIT1.2B440.6M(549.2M)(609.2M)(876.7M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Sep 1, 2026